BioSpace News Archive

Pharm Country

electroCore to Present at the HC Wainwright 23rd Annual Global Investment Conference

electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that its management team will give a corporate presentation at the HC Wainwright 23rd Annual Global Investment Conference.

August 31, 2021
·
1 min read
Drug Development

Adial Pharmaceuticals Exceeds Enrollment Target in ONWARD™ Phase 3 Trial of AD04 for the Treatment of Patients with Alcohol Use DisorderONWARD trial enrollment closed; trial completion expected in Q1 2022

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), announces it has successfully enrolled 302 patients across 25 clinical sites and has now closed enrollment for its ONWARD™ Phase 3 trial.

August 31, 2021
·
5 min read
Biotech Beach

Avidity Biosciences to Participate in Upcoming Investor Conferences - Aug 31, 2021

Avidity Biosciences, Inc. a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that the Avidity management team will be participating at the following conferences

August 31, 2021
·
2 min read
CVR Medical Corp. Announces Completion of 2021 2nd Quarter Financial Statement

CVR Medical Corp. is a healthcare company that operates in the medical device industry focused on the commercialization of its disruptive, proprietary Carotid Stenotic Scan device (the “CSS”).

August 31, 2021
·
3 min read
Defence Therapeutics Files Acid-Based Hydrogels USA Provisional Patent Application

Hydrogels are cross-linked polymer networks that can swell and retain a significant amount of water within its structure.

August 31, 2021
·
4 min read
Pharm Country

BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium

BioSig Technologies, Inc. today announced that the Company had been invited to participate in The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Symposium, due to take place virtually on September 11, 2021

August 31, 2021
·
6 min read
Deals

Vitro Biopharma Acquires Fitore Nutrition and Infinivive MD, Adding Revenues from Innovative Stem Cell Activation Products and Topical Cosmetic Stem Cell Serums.

Vitro Biopharma, Inc. announced the acquisition of Fitore Nutrition and Infinivive MD. Fitore, a private company headquartered in Denver, Colorado creates clinically validated supplements and sells them direct to consumers via their unique digital marketing platform and SEO expertise.

August 31, 2021
·
5 min read
Genetown

Jacobio Pharmaceuticals Announces 2021 Interim Results

Jacobio Pharmaceuticals (“Jacobio”, 1167.HK) announced its results for the first half of 2021. Investment in R&D for the clinical-stage biotech firm reached 175 million yuan (approx. US$27 million) for the half year, up 146 percent year-on-year.

August 31, 2021
·
4 min read
Drug Development

Pharmaxis Treatment to Prevent Wound and Burns Scars Clears Phase 1 Trial

Pharmaxis announced that its novel topical drug treatment for scarring has delivered positive Phase 1 clinical trial results and will now advance to the next stage of development in patients.

August 31, 2021
·
5 min read
Genetown

Karuna Therapeutics to Present at the Citi 16th Annual BioPharma Virtual Conference

Karuna Therapeutics, Inc. announced that Steve Paul, M.D., chief executive officer, president and chairman, will participate in a panel titled “Emerging Therapies for Psychiatric Disorders” at the Citi 16th Annual BioPharma Virtual Conference on September 8, 2021, at 10:40 a.m. ET.

August 31, 2021
·
1 min read